LIPITENSION: Interplay between dyslipidemia and hypertension
JJ Dalal, TNC Padmanabhan, P Jain… - Indian journal of …, 2012 - journals.lww.com
The burden of cardiovascular disease (CVD) is increasing worldwide. The increase in the
burden is a major concern in developing countries like India. It is well-established that …
burden is a major concern in developing countries like India. It is well-established that …
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European …
Task Force Members, G Montalescot… - European heart …, 2013 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering
TR Pedersen - American Journal of Cardiovascular Drugs, 2010 - Springer
Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are extremely effective at
reducing low-density lipoprotein (LDL) cholesterol and have been demonstrated to reduce …
reducing low-density lipoprotein (LDL) cholesterol and have been demonstrated to reduce …
[PDF][PDF] 2013 ESC guidelines on the management of stable coronary artery disease
R OUS - European heart journal, 2013 - beta.legeforeningen.no
Redusert venstre ventrikkelfunksjon er en selvstendig og sterkt ugunstig prognostisk faktor.
Vurdering av venstre ventrikkelfunksjon med for eksempel ekkokardiografi anbefales utført …
Vurdering av venstre ventrikkelfunksjon med for eksempel ekkokardiografi anbefales utført …
Hematologic parameters and angiographic progression of coronary atherosclerosis
N Kalay, O Dogdu, F Koc, M Yarlıoglues, I Ardic… - …, 2012 - journals.sagepub.com
Hematologic parameters have prognostic importance in cardiovascular disease. However,
the relation between atherosclerosis progression and hematologic parameters is not well …
the relation between atherosclerosis progression and hematologic parameters is not well …
Genetic association and potential mediators between sarcopenia and coronary heart disease: A bidirectional two-sample, two-step mendelian randomization study
J He, M Huang, N Li, L Zha, J Yuan - Nutrients, 2023 - mdpi.com
Objective: To elucidate the bidirectional correlation of sarcopenia with coronary heart
disease (CHD), as well as to investigate the mediating role of cardiometabolic factors and …
disease (CHD), as well as to investigate the mediating role of cardiometabolic factors and …
Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol
O Bayturan, S Kapadia, SJ Nicholls, EM Tuzcu… - Journal of the American …, 2010 - jacc.org
Objectives: The purpose of this study was to characterize the determinants of plaque
progression despite achieving very low levels of low-density lipoprotein cholesterol (LDL-C) …
progression despite achieving very low levels of low-density lipoprotein cholesterol (LDL-C) …
The burden of major adverse cardiac events in patients with coronary artery disease
IT Tsai, CP Wang, YC Lu, WC Hung, CC Wu… - BMC cardiovascular …, 2017 - Springer
Background Patients with a history of cardiovascular disease are at high risk of developing
secondary major adverse cardiac events (MACE). This study aimed to identify independent …
secondary major adverse cardiac events (MACE). This study aimed to identify independent …
Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study
MJ Pletcher, K Bibbins-Domingo, K Liu… - Annals of internal …, 2010 - acpjournals.org
Background: Dyslipidemia causes coronary heart disease in middle-aged and elderly
adults, but the consequences of lipid exposure during young adulthood are unclear …
adults, but the consequences of lipid exposure during young adulthood are unclear …
Impact of olmesartan on progression of coronary atherosclerosis: a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of olmesarten on …
A Hirohata, K Yamamoto, T Miyoshi, K Hatanaka… - Journal of the American …, 2010 - jacc.org
Objectives: The aim of this study was to evaluate the impact of olmesartan on progression of
coronary atherosclerosis. Background: Prior intravascular ultrasound (IVUS) trial results …
coronary atherosclerosis. Background: Prior intravascular ultrasound (IVUS) trial results …